Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 4, 1996, Pages 1568-1574

  Dorella, Mauro ^a   Giusto, Marta ^a   Da Tos, Virgilio ^a   Campagnolo, Maria ^a   Palatini, Paolo ^a   Rossi, Gianpaolo ^a   Ceolotto, Giulio ^a   Felice, Marcella ^a   Semplicini, Andrea ^a,b   Del Prato, Stefano ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Istituto di Medicina Clinica Padova   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PLACEBO;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; ERYTHROCYTE MEMBRANE; FEMALE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINISM; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; SODIUM EXCRETION;

ADULT; AGED; ALANINE; ALDOSTERONE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPINEPHRINE; ERYTHROCYTE MEMBRANE; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLYCEROL; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; KETONE BODIES; KIDNEY; LACTATES; MALE; METFORMIN; MIDDLE AGED; NOREPINEPHRINE; PLACEBOS; RENIN; SODIUM;

EID: 9244227632     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.4.1568     Document Type: Article

References (43)

1. Ferrannini E, Buzzigoli G, Bonadonna R, et al. 1987 Insulin resistance and hypertension. N Engl J Med. 317:350-357.
2. Pollare T, Lithell H, Berne CP. 1990 Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 39:167-174.
3. De Fronzo RA. 1981 The effect of insulin on renal sodium metabolism. Diabetologia. 21:165-171.
4. Moore RD. 1983 Effects of insulin upon ion transport. Biochem Biophys Acta. 737:1-49.
5. Lembo G, Napoli R, Capaldo B, et al. 1992 Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest. 90:24-29.
6. Stout RW. 1990 Insulin and atheroma: 20-yr perspective. Diabetes Care. 13: 631-654.
7. Krowtkiewski M, Mandroukas K, Sjöström L, et al. 1979 Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism. 6:650-658.
8. Landin KK, Tengborn L, Smith U. 1991 Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med. 229:181-187.
9. Gudbjörnsdottir S, Friberg, P, Elam M, Attvall S, Lönnroth P, Wallin BG. 1994 The effect of metformin and insulin on sympathetic nerve activity norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men. Blood Pressure. 3:394-403.
10. Fifth Report on the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) 1993 Arch Intern Med. 153:154-183.
11. National Diabetes Data Group. 1979 Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057.
12. De Fronzo RA, Tobin D, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 273:E214-E223.
13. Du Bois D, Du Bois F. 1916 A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 17:863-871.
14. Nosadini R, Trevisan R, Fioretto P, et al. 1989 Kidney hemodynamics after ketone body and amino acid infusion in normal and IDDM subjects. Diabetes. 38:75-83.
15. Thomsen K. 1984 A new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron. 37:217-233.
16. Canessa M, Bize I, Adragna N, Tosteson DC. 1982 Cotransport of lithium and potassium in human red cells. J Gen Physiol. 80:149-168.
17. + exchanger. J Membr Biol. 107:219-228.
18. + exchange in patients with essential hypertension. Am J Hypertension. 2:903-908.
19. Herbert V, Lan K, Gottlieb CW, Bleicher SH. 1965 Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 25:1375-1384.
20. Rossi GP, Deppieri O, Pessina AC. 1986 Effects of hemolysis on HPLC-ED measurements of plasma catecholamines. J Chromatogr. 380:117-121.
21. Avogaro A, Bristow JD, Bier DM, Cobelli C, Toffolo G. 1989 Stable-label intravenous glucose tolerance test minimal model. Diabetes. 38:1048-1055.
22. Simonson DC, De Fronzo RA. 1990 Indirect calorimetry: methodologic and interpretative problems. Am J Physiol. 258:E399-E412.
23. Hawk PD. 1967 Kjeldahl method. In: Practical physiological chemistry, 12th ed. Toronto: Blakiston; 814-822.
24. 2-glucose. Diabetes. 26: 1016-1023.
25. Czar JH. 1984 Biostatistical analysis, 2nd ed. Englewood Cliffs: Prentice-Hall.
26. Riccio A, Del Prato S, Vigili de Kreutzenberg S, Tiengo A. 1991 Glucose and lipid metabolism in non-insulin-dependent diabetes: effect of metformin. Diabetes Metab. 17:180-184.
27. Perriello G, Misericordia P, Volpi E, et al. 1994 Acute antihyperglycemic mechanisms of metformin in NIDDM: evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes. 43:920-928.
28. Giugliano D, De Rosa N, Di Mario G, et al. 1993 Metformin improves glucose and lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care. 16:1387-1390.
29. Reaven GM. 1990 Insulin and hypertension. Clin Exp Hypertension. [A]12: 803-816.
30. Ferrannini E, Haffner SM, Stern MP. 1990 Essential hypertension: an insulin resistant state. J Cardiovasc Pharmacol. 15(Suppl 5):S18-S25.
31. Hall JE, Summars RL, Brands MW, Keen H, Alonso-Galicia M. 1994 Resistance to metabolic actions of insulin and its role in hypertension. Am J Hypertension. 7:772-788.
32. Weidmann P, de Courten M, Böhlen L. 1993 Insulin resistance, hyperinsulinemia, and hypertension. J Hypertension. 11(Suppl 5):S27-S38.
33. Gill JS, Zezulka AV, Beevers DG, Davies. 1985 Relation between initial blood pressure and its fall with treatment. Lancet. 1:567-569.
34. Campbell IW, Duncan CD, Patton NW, et al. 1989 The effect of metformin on glycemic control, intermediary metabolism, and blood pressure in non-insulin-dependent diabetes mellitus. Diabetic Med. 6:249-256.
35. Dadone MM, Hassled SJ, Hunt SC, Smith JB, Ash KO, Williams RR. 1984 Genetic analysis of sodium-lithium countertransport in ten hypertension-prone kindreds. Am J Med. 17:565-577.
36. + exchange decreases the affinity of sodium sites. Kidney Int. 46:365-375.
37. Rowe JW, Young JB, Mikaner KL, Stevens AL, Pallotta J, Landsberg L. 1981 Effect of insulin and glucose infusions on sympathetic activity in normal man. Diabetes. 30:219-225.
38. Lembo G, Napoli R, Capaldo B, Saccà L. 1992 Abnormal sympathetic over-activity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest. 90:24-29.
39. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. 1991 Hyper-insulinemia produces both sympathetic neural activity and vasodilation in normal humans. J Clin Invest. 87:2246-2252.
40. Henrion D, Laher I. 1994 Insulin potentiates norepinephrine-induced vascular tone by activation of protein kinase C and tyrosine kinase. Can J Physiol Pharmacol. 72:849-854.
41. Ballerman BJ, Skorecki KL, Brenner BM. 1984 Reduced glomerular angiotensin II receptor density in early untreated diabetes in the rat. Am J Physiol. 247:F110-F116.
42. Oliver FJ, De la Rubia G, Feener EP, et al. 1991 Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem. 266:23251-23256.
43. Trevisan R, Fioretto P, Semplicini A, et al. 1990 Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes. 39:289-298.